LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Diagnostic Solutions Accelerate Diagnostics offers state-of-the-art in vitro diagnostic solutions that significantly reduce the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit automate sample preparation to deliver phenotypic antibiotic susceptibility results in approximately 7 hours, giving clinicians the ability to optimize treatment faster than traditional methods.

Competitive Edge in Antibiotic Resistance Amid global challenges of antibiotic resistance, Accelerate Diagnostics stands out with solutions that provide results 1-2 days faster than existing methods. This competitive advantage enhances patient care with quicker, tailored antibiotic selection, making it an attractive option for healthcare facilities aiming to improve treatment outcomes and combat antibiotic resistance effectively.

Revenue and Growth Potential With a revenue ranging between $50M - 100M and recent funding of $15M, Accelerate Diagnostics demonstrates financial stability and growth potential. This indicates a company that is well-positioned to invest in further innovation, expansion, and market penetration, presenting a lucrative sales opportunity for partners looking to collaborate with a financially healthy organization.

Addressing Critical Healthcare Needs Acceleration Diagnostics is dedicated to addressing critical healthcare needs related to sepsis and antibiotic resistance. Its advanced diagnostic tools and technologies directly contribute to improving patient outcomes by providing timely and accurate information for clinicians to make informed decisions. Partnering with Accelerate Diagnostics presents an opportunity to support healthcare providers in meeting these pressing challenges effectively.

Expanding Market Reach Located in Tucson, Arizona, Accelerate Diagnostics has positioned itself to tap into the growing medical equipment manufacturing market. With its focus on combating antibiotic resistance and sepsis, the company can leverage its innovative solutions to expand its market reach and partner with healthcare institutions globally, making it an appealing prospect for sales expansion into new territories.

Similar companies to Accelerate Diagnostics

Accelerate Diagnostics Tech Stack

Media & News

Accelerate Diagnostics's Email Address Formats

Accelerate Diagnostics uses at least 1 format(s):
Accelerate Diagnostics Email FormatsExamplePercentage
FLast@axdx.comJDoe@axdx.com
86%
Last@axdx.comDoe@axdx.com
12%
First.Last@axdx.comJohn.Doe@axdx.com
1%
FMiddleLast@axdx.comJMichaelDoe@axdx.com
1%

Frequently Asked Questions

Where is Accelerate Diagnostics's headquarters located?

Minus sign iconPlus sign icon
Accelerate Diagnostics's main headquarters is located at 3950 South Country Club Road Tucson, AZ 85714 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Accelerate Diagnostics's phone number?

Minus sign iconPlus sign icon
You can contact Accelerate Diagnostics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Accelerate Diagnostics's stock symbol?

Minus sign iconPlus sign icon
Accelerate Diagnostics is a publicly traded company; the company's stock symbol is AXDX.

What is Accelerate Diagnostics's official website and social media links?

Minus sign iconPlus sign icon
Accelerate Diagnostics's official website is axdx.com and has social profiles on LinkedIn.

How much revenue does Accelerate Diagnostics generate?

Minus sign iconPlus sign icon
As of September 2024, Accelerate Diagnostics's annual revenue reached $75M.

What is Accelerate Diagnostics's NAICS code?

Minus sign iconPlus sign icon
Accelerate Diagnostics's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Accelerate Diagnostics have currently?

Minus sign iconPlus sign icon
As of September 2024, Accelerate Diagnostics has approximately 201 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. P.CSO: R. H.Chief Financial Officer: S. R.. Explore Accelerate Diagnostics's employee directory with LeadIQ.

What industry does Accelerate Diagnostics belong to?

Minus sign iconPlus sign icon
Accelerate Diagnostics operates in the Medical Equipment Manufacturing industry.

What is Accelerate Diagnostics's email format?

Minus sign iconPlus sign icon
Accelerate Diagnostics's email format typically follows the pattern of . Find more Accelerate Diagnostics email formats with LeadIQ.

How much funding has Accelerate Diagnostics raised to date?

Minus sign iconPlus sign icon
As of September 2024, Accelerate Diagnostics has raised $15M in funding. The last funding round occurred on Jan 19, 2024 for $15M.

When was Accelerate Diagnostics founded?

Minus sign iconPlus sign icon
Accelerate Diagnostics was founded in 2004.
Accelerate Diagnostics

Accelerate Diagnostics

Medical Equipment ManufacturingArizona, United States201-500 Employees

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

Section iconCompany Overview

Headquarters
3950 South Country Club Road Tucson, AZ 85714 US
Phone number
Website
axdx.com
Stock Symbol
AXDX
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2004
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $15M

    Accelerate Diagnostics has raised a total of $15M of funding over 12 rounds. Their latest funding round was raised on Jan 19, 2024 in the amount of $15M.

  • $50M$100M

    Accelerate Diagnostics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $15M

    Accelerate Diagnostics has raised a total of $15M of funding over 12 rounds. Their latest funding round was raised on Jan 19, 2024 in the amount of $15M.

  • $50M$100M

    Accelerate Diagnostics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.